The serum- & glucocorticoid-inducible kinase in the regulation of platelet function

Acta Physiologica

Volumn 213, Issue 1, 2015, Pages 181-190

  Lang, F ^a   Gawaz, M ^a   Borst, O ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ca2+; metabolic syndrome; Orai1; platelets; SGK1; thrombus formation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALCIUM ION; ENDOTHELIN; GLUCOCORTICOID; INTERLEUKIN 6; MINERALOCORTICOID; PLATELET DERIVED GROWTH FACTOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; THROMBIN; TRANSFORMING GROWTH FACTOR BETA; CALCIUM CHANNEL; PROTEIN SERINE THREONINE KINASE; SERUM-INDUCIBLE KINASE;

CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME STABILITY; HUMAN; HYPERGLYCEMIA; INFLAMMATION; ISCHEMIA; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE FUNCTION; ANIMAL; CALCIUM SIGNALING; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CALCIUM CHANNELS; CALCIUM SIGNALING; GLUCOCORTICOIDS; HUMANS; HYPERGLYCEMIA; PROTEIN-SERINE-THREONINE KINASES;

EID: 84940232500     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12334     Document Type: Review

References (96)

1. Alexandru, N., Popov, D., Sbarcea, A. & Amuzescu, M. 2007. Platelet free cytosolic calcium concentration during ageing of type 2 diabetic patients. Platelets 18, 473–480.
2. Authi, K.S. 2007. TRP channels in platelet function. Handb Exp Pharmacol 179, 425–443.
3. Authi, K.S. 2009. Orai1: a channel to safer antithrombotic therapy. Blood 113, 1872–1873.
4. Baker, R.G., Hayden, M.S. & Ghosh, S. 2011. NF-kappaB, inflammation, and metabolic disease. Cell Metab 13, 11–22.
5. Beaulieu, L.M., Lin, E., Morin, K.M., Tanriverdi, K. & Freedman, J.E. 2011. Regulatory effects of TLR2 on megakaryocytic cell function. Blood 117, 5963–5974.
6. BelAiba, R.S., Djordjevic, T., Bonello, S., Artunc, F., Lang, F., Hess, J. & Gorlach, A. 2006. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circ Res 98, 828–836.
7. Bergmeier, W. & Stefanini, L. 2009. Novel molecules in calcium signaling in platelets. J Thromb Haemost 7(Suppl 1), 187–190.
8. Berna-Erro, A., Galan, C., Dionisio, N., Gomez, L.J., Salido, G.M. & Rosado, J.A. 2012. Capacitative and non-capacitative signaling complexes in human platelets. Biochim Biophys Acta 1823, 1242–1251.
9. Borst, O., Munzer, P., Gatidis, S., Schmidt, E.M., Schonberger, T., Schmid, E., Towhid, S.T., Stellos, K., Seizer, P., May, A.E., Lang, F. & Gawaz, M. 2012a. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. Circ Res 111, 1297–1307.
10. Borst, O., Schmidt, E.M., Munzer, P., Schonberger, T., Towhid, S.T., Elvers, M., Leibrock, C., Schmid, E., Eylenstein, A., Kuhl, D., May, A.E., Gawaz, M. & Lang, F. 2012b. The serum- and glucocorticoid-inducible kinase 1 (SGK1) influences platelet calcium signaling and function by regulation of Orai1 expression in megakaryocytes. Blood 119, 251–261.
11. Borst, O., Walker, B., Munzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M. & Lang, F. 2013. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation. Cell Physiol Biochem 31, 914–924.
12. 2+ signaling and thrombus formation in klotho-deficient mice. FASEB J 28, 2108–2119.
13. Braun, A., Varga-Szabo, D., Kleinschnitz, C., Pleines, I., Bender, M., Austinat, M., Bosl, M., Stoll, G. & Nieswandt, B. 2009. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 113, 2056–2063.
14. Briet, M. & Schiffrin, E.L. 2013. Vascular actions of aldosterone. J Vasc Res 50, 89–99.
15. Chatterjee, M. & Gawaz, M. 2013. Platelet-derived CXCL12 (SDF-1alpha): basic mechanisms and clinical implications. J Thromb Haemost 11, 1954–1967.
16. Chen, J., De, S., Damron, D.S., Chen, W.S., Hay, N. & Byzova, T.V. 2004. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 104, 1703–1710.
17. Chen, X., Zhang, Y., Wang, Y., Li, D., Zhang, L., Wang, K., Luo, X., Yang, Z., Wu, Y. & Liu, J. 2013. PDK1 regulates platelet activation and arterial thrombosis. Blood 121, 3718–3726.
18. Dahlberg, J., Smith, G., Norrving, B., Nilsson, P., Hedblad, B., Engstrom, G., Lovkvist, H., Carlson, J., Lindgren, A. & Melander, O. 2011. Genetic variants in serum and glucocortocoid regulated kinase 1, a regulator of the epithelial sodium channel, are associated with ischaemic stroke. J Hypertens 29, 884–889.
19. Davenport, R. 2013. Pathogenesis of acute traumatic coagulopathy. Transfusion 53(Suppl 1), 23S–27S.
20. Denis, M.M., Tolley, N.D., Bunting, M., Schwertz, H., Jiang, H., Lindemann, S., Yost, C.C., Rubner, F.J., Albertine, K.H., Swoboda, K.J. et al. 2005. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 122, 379–391.
21. Dionisio, N., Redondo, P.C., Jardin, I. & Rosado, J.A. 2012. Transient receptor potential channels in human platelets: expression and functional role. Curr Mol Med 12, 1319–1328.
22. El Haouari, M. & Rosado, J.A. 2008. Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review. Blood Cells Mol Dis 41, 119–123.
23. 2+-channel Orai1/STIM1 by serum- and glucocorticoid-inducible kinase 1 (SGK1). FASEB J 25, 2012–2021.
24. Fahim, M.A. & El-Sabban, F.F. 2001. Garlic prevents ultrastructural alterations caused by dehydration in mouse cerebral microvessels. Anat Rec 263, 85–90.
25. Fateh-Moghadam, S., Li, Z., Ersel, S., Reuter, T., Htun, P., Plockinger, U., Bocksch, W., Dietz, R. & Gawaz, M. 2005. Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arterioscler Thromb Vasc Biol 25, 1299–1303.
26. Ferreira, I.A., Mocking, A.I., Feijge, M.A., Gorter, G., van Haeften, T.W., Heemskerk, J.W. & Akkerman, J.W. 2006. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 26, 417–422.
27. Ferroni, P., Vazzana, N., Riondino, S., Cuccurullo, C., Guadagni, F. & Davi, G. 2012. Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities. Antioxid Redox Signal 17, 1447–1485.
28. Feske, S. 2010. CRAC channelopathies. Pflugers Arch 460, 417–435.
29. Galan, C., Zbidi, H., Bartegi, A., Salido, G.M. & Rosado, J.A. 2009. STIM1, Orai1 and hTRPC1 are important for thrombin- and ADP-induced aggregation in human platelets. Arch Biochem Biophys 490, 137–144.
30. Gawaz, M. 2004. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 61, 498–511.
31. Gawaz, M. 2011. Intelligent platelet inhibitors are on the horizon. Arterioscler Thromb Vasc Biol 31, 1949–1950.
32. Gawaz, M. & Vogel, S. 2013. Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood 122, 2550–2554.
33. Gawaz, M., Langer, H. & May, A.E. 2005. Platelets in inflammation and atherogenesis. J Clin Invest 115, 3378–3384.
34. Gilio, K., van Kruchten, R., Braun, A., Berna-Erro, A., Feijge, M.A., Stegner, D., van der Meijden, P.E., Kuijpers, M.J., Varga-Szabo, D., Heemskerk, J.W. & Nieswandt, B. 2010. Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem 285, 23629–23638.
35. Grosse, J., Braun, A., Varga-Szabo, D., Beyersdorf, N., Schneider, B., Zeitlmann, L., Hanke, P., Schropp, P., Muhlstedt, S., Zorn, C. et al. 2007. An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice. J Clin Invest 117, 3540–3550.
36. Hunter, R.W. & Hers, I. 2009. Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function. J Thromb Haemost 7, 2123–2130.
37. Jardin, I., Gomez, L.J., Salido, G.M. & Rosado, J.A. 2009a. Dynamic interaction of hTRPC6 with the Orai1-STIM1 complex or hTRPC3 mediates its role in capacitative or non-capacitative Ca(2+) entry pathways. Biochem J 420, 267–276.
38. 2+ concentration through plasma membrane STIM1. Biochim Biophys Acta 1793, 1614–1622.
39. Jardin, I., Lopez, J.J., Zbidi, H., Bartegi, A., Salido, G.M. & Rosado, J.A. 2011. Attenuated store-operated divalent cation entry and association between STIM1, Orai1, hTRPC1 and hTRPC6 in platelets from type 2 diabetic patients. Blood Cells Mol Dis 46, 252–260.
40. Karin, M., Yamamoto, Y. & Wang, Q.M. 2004. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3, 17–26.
41. Kleinewietfeld, M., Manzel, A., Titze, J., Kvakan, H., Yosef, N., Linker, R.A., Muller, D.N. & Hafler, D.A. 2013. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518–522.
42. van Kruchten, R., Braun, A., Feijge, M.A., Kuijpers, M.J., Rivera-Galdos, R., Kraft, P., Stoll, G., Kleinschnitz, C., Bevers, E.M., Nieswandt, B. & Heemskerk, J.W. 2012. Antithrombotic potential of blockers of store-operated calcium channels in platelets. Arterioscler Thromb Vasc Biol 32, 1717–1723.
43. Kusch, A., Hoff, U., Bubalo, G., Zhu, Y., Fechner, M., Schmidt-Ullrich, R., Marko, L., Muller, D.N., Schmidt-Ott, K.M., Gurgen, D., Blum, M., Schunck, W.H. & Dragun, D. 2013. Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. Acta Physiol (Oxf) 208, 25–40.
44. Lang, F. & Stournaras, C. 2013. Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth. Hormones (Athens) 12, 160–171.
45. Lang, F., Bohmer, C., Palmada, M., Seebohm, G., Strutz-Seebohm, N. & Vallon, V. 2006. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 86, 1151–1178.
46. Lang, F., Gorlach, A. & Vallon, V. 2009. Targeting SGK1 in diabetes. Expert Opin Ther Targets 13, 1303–1311.
47. 2+ signalling in platelets. Thromb Haemost 110, 925–930.
48. Li, D., August, S. & Woulfe, D.S. 2008. GSK3beta is a negative regulator of platelet function and thrombosis. Blood 111, 3522–3530.
49. Lindemann, S., Tolley, N.D., Eyre, J.R., Kraiss, L.W., Mahoney, T.M. & Weyrich, A.S. 2001. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J Biol Chem 276, 33947–33951.
50. 2+ entry and triggering of cell membrane scrambling in platelets by mineralocorticoid DOCA. Kidney Blood Press Res 38, 21–30.
51. Lu, K.C., Shieh, S.D., Lin, S.H., Chyr, S.H., Lin, Y.F., Diang, L.K., Li, B.L., Sheu, W.H. & Ding, Y.A. 1994. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure. Q J Med 87, 359–365.
52. Mattoscio, D., Evangelista, V., De Cristofaro, R., Recchiuti, A., Pandolfi, A., Di Silvestre, S., Manarini, S., Martelli, N., Rocca, B., Petrucci, G. et al. 2010. Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J 24, 3970–3980.
53. May, A.E., Seizer, P. & Gawaz, M. 2008. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 28, s5–s10.
54. 2+ signalling and platelet count. J Physiol 588, 1399–1406.
55. Moody, W.E., Edwards, N.C., Chue, C.D., Ferro, C.J. & Townend, J.N. 2013. Arterial disease in chronic kidney disease. Heart 99, 365–372.
56. Moore, S.F., van den Bosch, M.T., Hunter, R.W., Sakamoto, K., Poole, A.W. & Hers, I. 2013. Dual regulation of glycogen synthase kinase 3 (GSK3)alpha/beta by protein kinase C (PKC)alpha and Akt promotes thrombin-mediated integrin alphaIIbbeta3 activation and granule secretion in platelets. J Biol Chem 288, 3918–3928.
57. Munzer, P., Tolios, A., Pelzl, L., Schmid, E., Schmidt, E.M., Walker, B., Frohlich, H., Borst, O., Gawaz, M. & Lang, F. 2013. Thrombin-sensitive expression of the store operated Ca(2+) channel Orai1 in platelets. Biochem Biophys Res Commun 436, 25–30.
58. Munzer, P., Borst, O., Walker, B., Schmid, E., Feijge, M.A., Cosemans, J.M., Chatterjee, M., Schmidt, E.M., Schmidt, S., Towhid, S.T. et al. 2014. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation. Arterioscler Thromb Vasc Biol 34, 61–71.
59. Mutoh, A., Isshiki, M. & Fujita, T. 2008. Aldosterone enhances ligand-stimulated nitric oxide production in endothelial cells. Hypertens Res 31, 1811–1820.
60. Nemmar, A., Raza, H., Subramaniyan, D., Yasin, J., John, A., Ali, B.H. & Kazzam, E.E. 2013. Short-term systemic effects of nose-only cigarette smoke exposure in mice: role of oxidative stress. Cell Physiol Biochem 31, 15–24.
61. O'Brien, K.A., Stojanovic-Terpo, A., Hay, N. & Du, X. 2011. An important role for Akt3 in platelet activation and thrombosis. Blood 118, 4215–4223.
62. 2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol 302, C405–C411.
63. Oh-hashi, S., Takata, M., Ueno, H., Tomoda, F., Yasumoto, K., Iida, H. & Sasayama, S. 1992. Cytosolic free calcium concentration in platelets in patients with renovascular hypertension and primary aldosteronism. J Hum Hypertens 6, 71–74.
64. Pabla, R., Weyrich, A.S., Dixon, D.A., Bray, P.F., McIntyre, T.M., Prescott, S.M. & Zimmerman, G.A. 1999. Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol 144, 175–184.
65. Palmer, S.C., Di Micco, L., Razavian, M., Craig, J.C., Perkovic, V., Pellegrini, F., Jardine, M.J., Webster, A.C., Zoungas, S. & Strippoli, G.F. 2013. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev, 2, CD008834.
66. Pasham, V., Rotte, A., Gu, S., Yang, W., Bhandaru, M., Rexhepaj, R., Pathare, G. & Lang, F. 2013. Upregulation of Intestinal NHE3 Following Saline Ingestion. Kidney Blood Press Res 37, 48–57.
67. Pelzl, L., Tolios, A., Schmidt, E.M., Alesutan, I., Walker, B., Munzer, P., Borst, O., Gawaz, M. & Lang, F. 2012. Translational regulation of the serum- and glucocorticoid-inducible kinase-1 (SGK1) in platelets. Biochem Biophys Res Commun 425, 1–5.
68. Pelzl, L., Fakhri, H., Umbach, A.T., Gawaz, M., Paulmichl, M. & Lang, F. 2013. Sgk1 sensitive Pendrin expression in murine platelets. Cell Physiol Biochem 32, S210–S220.
69. 2+ entry but normal agonist-induced activation responses in TRPC6-deficient mouse platelets. J Thromb Haemost 10, 419–429.
70. Rosskopf, D. 1999. Sodium-hydrogen exchange and platelet function. J Thromb Thrombolysis 8, 15–24.
71. Ruggeri, Z.M. 2002. Platelets in atherothrombosis. Nat Med 8, 1227–1234.
72. Schmid, E., Bhandaru, M., Nurbaeva, M.K., Yang, W., Szteyn, K., Russo, A., Leibrock, C., Tyan, L., Pearce, D., Shumilina, E. & Lang, F. 2012. SGK3 regulates Ca(2+) entry and migration of dendritic cells. Cell Physiol Biochem 30, 1423–1435.
73. Schmidt, E.M., Munzer, P., Borst, O., Kraemer, B.F., Schmid, E., Urban, B., Lindemann, S., Ruth, P., Gawaz, M. & Lang, F. 2011. Ion channels in the regulation of platelet migration. Biochem Biophys Res Commun 415, 54–60.
74. Schmidt, E.M., Kraemer, B.F., Borst, O., Munzer, P., Schonberger, T., Schmidt, C., Leibrock, C., Towhid, S.T., Seizer, P., Kuhl, D., Stournaras, C., Lindemann, S., Gawaz, M. & Lang, F. 2012. SGK1 sensitivity of platelet migration. Cell Physiol Biochem 30, 259–268.
75. Schoenwaelder, S.M., Yuan, Y., Josefsson, E.C., White, M.J., Yao, Y., Mason, K.D., O'Reilly, L.A., Henley, K.J., Ono, A., Hsiao, S. et al. 2009. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 114, 663–666.
76. Schwertz, H., Tolley, N.D., Foulks, J.M., Denis, M.M., Risenmay, B.W., Buerke, M., Tilley, R.E., Rondina, M.T., Harris, E.M., Kraiss, L.W., Mackman, N., Zimmerman, G.A. & Weyrich, A.S. 2006. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 203, 2433–2440.
77. Seizer, P., Gawaz, M. & May, A.E. 2008. Platelet-monocyte interactions–a dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr Med Chem 15, 1976–1980.
78. Sekizawa, N., Yoshimoto, T., Hayakawa, E., Suzuki, N., Sugiyama, T. & Hirata, Y. 2011. Transcriptome analysis of aldosterone-regulated genes in human vascular endothelial cell lines stably expressing mineralocorticoid receptor. Mol Cell Endocrinol 341, 78–88.
79. Smith, K.A. & Yuan, J.X. 2012. CRACing the cluster: functionally active Orai1 channels in the absence of clustering with STIM1. Circ Res 111, 9–11.
80. Spinelli, S.L., Casey, A.E., Pollock, S.J., Gertz, J.M., McMillan, D.H., Narasipura, S.D., Mody, N.A., King, M.R., Maggirwar, S.B., Francis, C.W., Taubman, M.B., Blumberg, N. & Phipps, R.P. 2010a. Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler Thromb Vasc Biol 30, 591–598.
81. Spinelli, S.L., Maggirwar, S.B., Blumberg, N. & Phipps, R.P. 2010b. Nuclear emancipation: a platelet tour de force. Sci Signal 3, pe37.
82. 2+ channel Orai1 expression upon platelet activation and in patients with acute myocardial infarction. Thromb Haemost 110, 386–389.
83. Tomasiak, M., Stelmach, H., Rusak, T., Ciborowski, M. & Radziwon, P. 2007. The involvement of Na+/K(+)-ATPase in the development of platelet procoagulant response. Acta Biochim Pol 54, 625–639.
84. Towhid, S.T., Schmidt, E.M., Tolios, A., Munzer, P., Schmid, E., Borst, O., Gawaz, M., Stegmann, E. & Lang, F. 2013. Stimulation of platelet death by vancomycin. Cell Physiol Biochem 31, 102–112.
85. Varga-Szabo, D., Braun, A., Kleinschnitz, C., Bender, M., Pleines, I., Pham, M., Renne, T., Stoll, G. & Nieswandt, B. 2008. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med 205, 1583–1591.
86. Varga-Szabo, D., Braun, A. & Nieswandt, B. 2009. Calcium signaling in platelets. J Thromb Haemost 7, 1057–1066.
87. Voelkl, J., Pasham, V., Ahmed, M.S., Walker, B., Szteyn, K., Kuhl, D., Metzler, B., Alesutan, I. & Lang, F. 2013. Sgk1-dependent stimulation of cardiac Na+/H+ exchanger Nhe1 by dexamethasone. Cell Physiol Biochem 32, 25–38.
88. Wang, B., Peng, Y., Dong, J., Lin, J., Wu, C., Su, Y., Fang, H., Wang, L., Huang, K. & Li, D. 2013. Human platelets express functional thymic stromal lymphopoietin receptors: a potential role in platelet activation in acute coronary syndrome. Cell Physiol Biochem 32, 1741–1750.
89. 2+ in platelets from patients with uremia. Blood 73, 172–176.
90. Weng, Z., Li, D., Zhang, L., Chen, J., Ruan, C., Chen, G., Gartner, T.K. & Liu, J. 2010. PTEN regulates collagen-induced platelet activation. Blood 116, 2579–2581.
91. Weyrich, A.S., Schwertz, H., Kraiss, L.W. & Zimmerman, G.A. 2009. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost 7, 241–246.
92. Wolfs, J.L., Wielders, S.J., Comfurius, P., Lindhout, T., Giddings, J.C., Zwaal, R.F. & Bevers, E.M. 2006. Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel. Blood 108, 2223–2228.
93. Woulfe, D., Jiang, H., Morgans, A., Monks, R., Birnbaum, M. & Brass, L.F. 2004. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 113, 441–450.
94. Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., Regev, A. & Kuchroo, V.K. 2013. Induction of pathogenic T17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513–517.
95. Yin, H., Stojanovic, A., Hay, N. & Du, X. 2008. The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. Blood 111, 658–665.
96. Zbidi, H., Lopez, J.J., Amor, N.B., Bartegi, A., Salido, G.M. & Rosado, J.A. 2009. Enhanced expression of STIM1/Orai1 and TRPC3 in platelets from patients with type 2 diabetes mellitus. Blood Cells Mol Dis 43, 211–213.